The earnings call highlights a strong growth trajectory with significant increases in revenue and gross margins, successful capital raise, and positive clinical outcomes. However, there are challenges in maintaining revenue growth on a quarterly basis and the company continues to operate at a net loss, albeit improved. Overall, the company is well-positioned for future growth with new applications and strategic partnerships.

Company Guidance -

Q3 2025

In the second quarter of fiscal year 2025, NeuroOne Medical Technologies provided guidance indicating a significant increase in product revenue and gross margins. The company expects product revenue to range between $8 million and $10 million, representing an increase of 132% to 190% over fiscal 2024. Product gross margins are anticipated to be between 47% and 51%, up from 31% in the previous year. This guidance excludes the $3 million upfront license payment received from Zimmer Biomet. NeuroOne has also bolstered its financial position with a successful capital raise, adding $8.2 million in net proceeds, and the company believes it is fully funded through at least fiscal 2026. The company remains debt-free and is focused on ramping revenues through strategic partnerships and expanding its product offerings, particularly in international markets.

Strong Revenue Growth

Product revenue increased 97% to $4.7 million in the first half of fiscal 2025 compared to the same period in fiscal 2024.

Significant Improvement in Gross Margins

Product gross margins increased to 57.9% in the first half of fiscal 2025, more than doubling from the first half of fiscal 2024.

Successful Capital Raise

The company raised $8.2 million in net proceeds from a successful capital raise, ensuring funding through at least fiscal 2026.

Positive Clinical Outcomes

Majority of patients treated with the OneRF ablation system are now seizure free, with one patient being seizure free for almost an entire year.

Expansion into New Applications

Filed a 510(k) submission with the FDA for the OneRF trigeminal nerve ablation system ahead of schedule, with potential revenue generation by late 2025.

NeuroOne Medical Technologies (NMTC) Earnings, Revenues Date & History

The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced

Daily Earnings Calendar >

NMTC Earnings History

Report Date	Fiscal Quarter	Forecast / EPS	Last Year's EPS	EPS YoY Change	Slides	Play Transcript
Aug 14, 2025	2025 (Q3)	-0.05 / -	-0.1	―	―	―
May 13, 2025	2025 (Q2)	-0.09 / -0.07	-0.11	36.36% (+0.04)	―
Feb 12, 2025	2025 (Q1)	- / 0.06	-0.14	142.86% (+0.20)	―
Dec 17, 2024	2024 (Q4)	- / -0.11	-0.171	35.67% (+0.06)	―
Aug 14, 2024	2024 (Q3)	-0.09 / -0.10	-0.2	50.00% (+0.10)	―
May 14, 2024	2024 (Q2)	-0.09 / -0.11	-0.21	47.62% (+0.10)	―
Feb 13, 2024	2024 (Q1)	-0.14 / -0.14	-0.11	-27.27% (-0.03)	―
Dec 14, 2023	2023 (Q4)	-0.17 / -0.17	-0.08	-113.75% (-0.09)	―
Aug 14, 2023	2023 (Q3)	-0.20 / -0.20	-0.17	-17.65% (-0.03)	―
May 11, 2023	2023 (Q2)	-0.20 / -0.21	-0.19	-10.53% (-0.02)	―

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat

Missed

NMTC Earnings-Related Price Changes

Report Date	Price 1 Day Before	Price 1 Day After	Percentage Change
May 13, 2025	$0.62	$0.64	+3.23%
Feb 12, 2025	$1.09	$1.12	+2.75%
Dec 17, 2024	$0.76	$0.79	+3.95%
Aug 14, 2024	$0.74	$0.73	-1.35%

Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.

FAQ

When does NeuroOne Medical Technologies (NMTC) report earnings?

NeuroOne Medical Technologies (NMTC) is schdueled to report earning on Aug 14, 2025, Before Open (Confirmed).

What is NeuroOne Medical Technologies (NMTC) earnings time?

NeuroOne Medical Technologies (NMTC) earnings time is at Aug 14, 2025, Before Open (Confirmed).

Where can I see when companies are reporting earnings?

You can see which companies are reporting today on our designated earnings calendar.

What companies are reporting earnings today?

You can see a list of the companies which are reporting today on TipRanks earnings calendar.

What is NMTC EPS forecast?

NMTC EPS forecast for the fiscal quarter 2025 (Q3) is -0.05.

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing